Kim, Jwa Hoon
Ryu, Min-Hee
Park, Young Soo
Ma, Jungeun
Lee, Sun Young
Kim, Deokhoon
Kang, Yoon-Koo
Article History
Received: 24 January 2022
Accepted: 1 April 2022
First Online: 9 April 2022
Declarations
:
: The study was approved by the ethics committee/Institutional Review Board of the Asan Medical Center (study number: 2015–0178). The need for informed consent was waived by the ethics committee/Institutional Review Board of the Asan Medical Center (study number: 2015–0178), because of the prospective nature of the study. This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice.
: Not applicable.
: Yoon-Koo Kang has served as a consultant for Ono, BMS, Merck Serono, Astellas, Daehwa, LSK Biopharma, and Astra Zeneca Pharmaceutical outside of the submitted work. The other authors have no conflicts of interest to declare.